ClinicalTrials.Veeva

Menu

Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Multidrug-resistant Gram-negative Bacteria Infection

Treatments

Other: Therapeutic drug monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT03007290
Colistin_TDM

Details and patient eligibility

About

Clinical usefulness of therapeutic drug monitoring of colistin in patients treated with colistin

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years old.
  • Those who receive colistin therapy for the treatment of multi-drug resistant gram negative bacteria infection.

Exclusion criteria

  • Those who received colistin therapy less than 48 hours
  • Those who received colistin therapy through the bronchus

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Treatment group
Experimental group
Description:
Group with therapeutic drug monitoring
Treatment:
Other: Therapeutic drug monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems